Style | Citing Format |
---|---|
MLA | Roostaee M, et al.. "Composition, Preparation Methods, and Applications of Nanoniosomes As Codelivery Systems: A Review of Emerging Therapies With Emphasis on Cancer." Nanoscale, vol. 16, no. 6, 2023, pp. 2713-2746. |
APA | Roostaee M, Derakhshani A, Mirhosseini H, Banaee Mofakham E, Fathikarkan S, Mirinejad S, Sargazi S, Barani M (2023). Composition, Preparation Methods, and Applications of Nanoniosomes As Codelivery Systems: A Review of Emerging Therapies With Emphasis on Cancer. Nanoscale, 16(6), 2713-2746. |
Chicago | Roostaee M, Derakhshani A, Mirhosseini H, Banaee Mofakham E, Fathikarkan S, Mirinejad S, Sargazi S, Barani M. "Composition, Preparation Methods, and Applications of Nanoniosomes As Codelivery Systems: A Review of Emerging Therapies With Emphasis on Cancer." Nanoscale 16, no. 6 (2023): 2713-2746. |
Harvard | Roostaee M et al. (2023) 'Composition, Preparation Methods, and Applications of Nanoniosomes As Codelivery Systems: A Review of Emerging Therapies With Emphasis on Cancer', Nanoscale, 16(6), pp. 2713-2746. |
Vancouver | Roostaee M, Derakhshani A, Mirhosseini H, Banaee Mofakham E, Fathikarkan S, Mirinejad S, et al.. Composition, Preparation Methods, and Applications of Nanoniosomes As Codelivery Systems: A Review of Emerging Therapies With Emphasis on Cancer. Nanoscale. 2023;16(6):2713-2746. |
BibTex | @article{ author = {Roostaee M and Derakhshani A and Mirhosseini H and Banaee Mofakham E and Fathikarkan S and Mirinejad S and Sargazi S and Barani M}, title = {Composition, Preparation Methods, and Applications of Nanoniosomes As Codelivery Systems: A Review of Emerging Therapies With Emphasis on Cancer}, journal = {Nanoscale}, volume = {16}, number = {6}, pages = {2713-2746}, year = {2023} } |
RIS | TY - JOUR AU - Roostaee M AU - Derakhshani A AU - Mirhosseini H AU - Banaee Mofakham E AU - Fathikarkan S AU - Mirinejad S AU - Sargazi S AU - Barani M TI - Composition, Preparation Methods, and Applications of Nanoniosomes As Codelivery Systems: A Review of Emerging Therapies With Emphasis on Cancer JO - Nanoscale VL - 16 IS - 6 SP - 2713 EP - 2746 PY - 2023 ER - |